P. Sr, H. Jh, and I. Je, The biogenesis of platelets from megakaryocyte proplatelets, J. Clin. Invest, vol.115, issue.12, pp.3348-3354, 2005.

D. Vr and T. A. , Megakaryocyte development and platelet production, British Journal of Haematology, vol.134, issue.5, pp.453-466, 2006.

L. Mw, Megakaryocyte differentiation events, Semin. Hematol, vol.35, issue.3, pp.192-199, 1998.

C. I. Kelemen-e and T. B. , Demonstration and Some Properties of Human Thrombopoietin in Thrombocythaemic Sera, Acta Haematologica, vol.20, issue.6, pp.350-355, 1958.
DOI : 10.1159/000205503

J. A. Fleury-v, A. , T. C. , and A. M. Obrien-d, Human thrombopoietin structure?function relationships: identification of functionally important residues, Biochem. J, vol.333, issue.3, pp.729-734, 1998.

H. Haute-autorité-de-santé, Guide affection longue durée. Purpura thrombopénique immunologique de l'enfant et de l'adulte -Protocole national de diagnostic et de soins, 2009.

T. A. Shinjo-k, N. K. Nakamura-s, Y. M. , and T. T. , Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia, Leukemia, vol.12, issue.3, pp.295-300, 1998.
DOI : 10.1038/sj.leu.2400946

K. A. , B. G. , S. W. , K. S. , O. Fa et al., Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis, Blood, issue.9, pp.982720-2725, 2001.

L. , S. S. , S. A. , M. L. De, M. E. et al., Validation et classification clinicobiologique d'une thrombopénie, Annales de biologie clinique, vol.63, issue.6, pp.599-610, 2005.

L. , F. O. , and L. T. Le, Morphologie plaquettaire et mégacaryocytaire : aide au diagnostic des thrombopénies constitutionnelles. http://site.geht.org/site/Pratiques-Professionnelles/Thrombopenies- constitutionnelles/Morphologie-plaquettaire-et-diagnostic-des-thrombopenies- constitutionnelles_92, Centre de Référence des Pathologies Plaquettaires, 2011.

N. P. and N. At, Congenital disorders associated with platelet dysfunctions, Thromb. Haemost, vol.99, issue.2, pp.253-263, 2008.

L. Ja, A. Rk, A. , and B. Mc, Bernard-Soulier Syndrome, Blood, issue.12, pp.914397-4418, 1998.

D. X. and G. Mh, Integrin alpha IIb beta 3 and platelet function, Thromb. Haemost, vol.78, issue.1, pp.96-100, 1997.

J. Sp, The growing complexity of platelet aggregation, Blood, vol.109, issue.12, pp.5087-5095, 2007.

M. and I. Sj, Beyond hemostasis: the role of platelets in inflammation, malignancy and infection, Cardiovasc. Hematol. Disord. Drug Targets, vol.8, issue.2, pp.99-117, 2008.

L. Br, Exposure of platelet membrane phosphatidylserine regulates blood coagulation, Prog. Lipid Res, vol.42, issue.5, pp.423-438, 2003.

C. Ja, C. G. , T. S. , K. T. Belton-o, and M. Jp, Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions, Blood, vol.103, issue.6, pp.2096-2104, 2004.

S. Ss, M. Rp, W. As, M. Cn, H. Mr et al., Platelet functions beyond hemostasis, J. Thromb. Haemost, vol.7, issue.11, pp.1759-1766, 2009.

G. Gj, G. Tb, and S. Cc, Antimetastatic effects associated with platelet reduction, Proc. Natl. Acad. Sci. U S A, vol.61, issue.1, pp.6-52, 1968.

R. Zm and M. Gl, Adhesion mechanisms in platelet function, Circ. Res, vol.100, issue.12, pp.1673-1685, 2007.

K. D. , H. H. , K. Ws, and G. Am, Standardized flow cytometric method for the accurate determination of platelet counts in patients with severe thrombocytopenia, Cytometry, vol.42, issue.5, pp.284-289, 2000.

W. H. , F. M. , E. G. Schneider-c, B. N. , and D. , Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia, Blood, issue.10, pp.913601-3606, 1998.

S. Hc, B. C. , K. S. , C. A. , H. P. et al., Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion, Br. J. Haematol, vol.128, issue.4, pp.520-525, 2005.

C. Sd, S. A. , and M. De, Effects of storage of blood on stability of hematologic parameters, Am. J. Clin. Pathol, vol.76, issue.1, pp.67-69, 1981.

H. Haute-autorité-de-santé and . Anaes, Lecture critique de l'hémogramme : valeurs seuils à reconnaître comme probablement pathologiques et principales variations non pathologiques, 1997.

B. Dr and B. Hf, The determination of a reference range for new platelet parameters produced by the Bayer ADVIA120 full blood count analyser, Clin. Lab. Haematol, vol.22, issue.2, pp.103-107, 2000.

G. A. , L. P. , G. G. , A. F. , V. S. et al., Platelet count and parameters determined by the Bayer ADVIA 120 in reference subjects and patients, Clin. Lab. Haematol, vol.23, issue.3, pp.181-186, 2001.

B. C. , H. P. , and M. Sj, Continuing developments with the automated platelet count, Int. J. Lab. Hematol, vol.29, issue.2, pp.77-91, 2007.

S. Lm, O. Es, A. Nn, D. Ca, and M. Hj, Platelet counting by the coulter LH 750, sysmex XE 2100, and ad via 120: a comparative analysis using the RBC/platelet ratio reference method, Am. J. Clin. Pathol, vol.118, issue.2, pp.235-241, 2002.

K. Je, F. G. , M. J. , and Z. D. , Improved platelet counting using two-dimensional laser light scatter, Am. J. Clin. Pathol, vol.114, issue.2, pp.283-289, 2000.

B. G. , S. M. , and C. Ep, The reproducibility and constancy of the platelet count, Am. J. Clin. Pathol, vol.23, issue.1, pp.15-26, 1953.

A. Ka, Platelet counting. Is there room for improvement ?, Laboratory Hematology, vol.2, pp.139-143, 1996.

D. R. Von, Enumeration of platelets by multiparameter flow cytometry using platelet-specific antibodies and fluorescent reference particles, Clin. Lab. Haematol, vol.17, issue.2, pp.163-172, 1995.

H. P. , A. Ka, C. S. , C. L. , D. B. et al., An interlaboratory study of a candidate reference method for platelet counting, Am. J. Clin. Pathol, vol.115, issue.3, pp.448-459, 2001.

H. Haute-autorité-de-santé, Rapport d'évaluation technologique-Biologie des anomalies de l'hémostase, 2011.

R. Hm, M. M. , M. Jg, S. J. , A. Ka et al., Progressive platelet activation with storage: evidence for shortened surviva l of activated platelets after transfusion, Transfusion, issue.5, pp.31409-414, 1991.

B. Cl, C. M. , F. F. , G. P. , I. A. et al., Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine, Haematologica, vol.88, issue.5, pp.582-592, 2003.

N. M. , C. B. , M. A. , S. A. Jain-n, and G. Jm, The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin, J. Clin. Invest, vol.91, issue.4, pp.1775-1782, 1993.

D. Jg, Inherited thrombocytopenia: when a low platelet count does not mean ITP, Blood, vol.103, issue.2, pp.390-398, 2004.

G. Ae and K. K. , Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production, Curr. Opin. Pediatr, vol.16, issue.1, pp.15-22, 2004.

N. P. , P. A. , D. B. , D. Stazio-m, D. Pumpo-m et al., Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients, Haematologica, vol.89, pp.1219-1225, 2004.

T. C. Beauchamp-nicoud-a, P. V. Bader-meunier-b, T. G. , and D. M. , Les thrombopénies constitutionnelles : de la clinique à la biologie, Hématologie, vol.9, issue.6, pp.439-455, 2003.

O. Hd, S. Sj, H. La, V. Behrens-we, C. Ra et al., The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets, Blood, vol.55, issue.2, pp.243-252, 1980.

F. A. Sabri-s, B. S. , F. B. , C. S. , and J. , Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment, Blood, vol.108, issue.1, pp.134-140, 2006.
DOI : 10.1182/blood-2005-03-1219

D. Sb, J. D. Beardsley-d, B. S. , and L. Fp, Studies of a familial platelet disorder, Blood, vol.65, issue.3, pp.557-563, 1985.

H. Cy, O. B. , L. Rd, V. T. Saxena-r, and D. Db, Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2, Blood, vol.87, issue.12, pp.5218-5224, 1996.

B. D. , G. Ac, R. A. Balayn-n, G. L. , and R. P. , Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression, Blood, issue.13, pp.1202708-2718, 2012.

P. T. , S. A. Perrotta-s, P. , N. P. , and C. G. , Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2, Am. J. Hum. Genet, vol.88, issue.1, pp.115-120, 2011.

S. A. Dufour-c, L. F. , N. P. , A. C. , and R. V. , Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations, Haematologica, vol.92, issue.9, pp.1186-1193, 2007.

A. S. , P. Vb, L. S. Pinto-cisternas-j, and O. Jm, The IVIC syndrome: A new autosomal dominant complex pleiotropic syndrome with radial ray hypoplasia, hearing impairment, external ophthalmoplegia, and thrombocytopenia, American Journal of Medical Genetics, vol.6, issue.1, pp.25-59, 1980.

L. , V. J. , F. R. De, M. E. , L. J. et al., Plaquet'air -Thrombopénie «Paris-Trousseau» et syndrome de Jacobsen, 2000.

N. Ke, C. Jd, P. M. , W. Jg, O. Sh et al., Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1, Nat. Genet, vol.24, issue.3, pp.266-270, 2000.

F. K. , D. K. , M. G. Van-hoof-a, D. Vos-r, and T. C. , Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation, Blood, issue.1, pp.9885-92, 2001.

D. K. Van-geet-c, E. B. , V. J. , and H. Mf, Velocardiofacial Syndrome Patients with a Heterozygous Chromosome 22q11 Deletion Have Giant Platelets, Pediatric Research, vol.10, issue.4, pp.607-611, 1998.
DOI : 10.1016/S0950-3536(97)80048-0

K. Wha, H. J. , L. L. , S. H. , C. H. et al., Mutations in N BEAL2, encoding a BEACH protein, cause gray platelet syndrome, Nat. Genet, issue.8, pp.43738-740, 2011.

B. We, Mediterranean macrothrombocytopenia, Blood, vol.46, issue.2, pp.199-208, 1975.

H. A. , O. M. , L. J. , N. C. Brown-h, and F. Jp, Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based study, Thromb. Haemost, vol.105, issue.3, pp.501-508, 2011.

B. Cl and S. A. , Genetics of familial forms of thrombocytopenia, Hum. Genet, 2012.

S. A. , P. A. De, R. D. , C. E. , D. Stazio-m et al., Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations, Haematologica, issue.3, pp.96417-423, 2011.

P. A. Biino-g, B. V. Fierro-t, M. A. , and N. , Alteration of liver enzymes is a feature of the MYH9-related disease syndrome, PLoS One, vol.7, issue.4, pp.359-386, 2012.

L. J. , L. , B. M. , A. E. , D. Maistre-e et al., Plaquet'air -Anomalie de May-Hegglin, 2000.

H. Ke, C. , T. A. , R. , C. Le et al., Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes, Am. J. Hum. Genet, vol.69, issue.5, pp.1033-1045, 2001.

N. At, N. P. Fiore-m, and P. X. , Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models, Blood, vol.118, issue.23, pp.1185996-6005, 2011.

N. At, Glanzmann thrombasthenia, Orphanet Journal of Rare, vol.Diseases, pp.1-10, 2006.

N. At, P. X. , F. M. Heilig-r, and N. P. , Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the ?IIb?3 integrin, Semin. Thromb. Hemost, vol.37, issue.6, pp.698-706, 2011.

G. C. , S. A. , W. Na, S. , R. A. et al., A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia, Blood, issue.7, pp.1113407-3414, 2008.

M. , F. C. , T. , C. Em, and D. L. , Mise au point : la maladie du pool vide plaquettaire, Annales de Biologie Clinique, vol.66, issue.4, pp.365-369, 2008.

T. Satta-n, F. E. , M. D. , and F. J. , Le syndrome de Scott : un témoin de l'importance des phospholipides dans les réactions de la coagulation et une référence pour une nouvelle approche pharmacologique du risque thrombotique, Hématologie, vol.2, issue.2, pp.111-119, 1996.

L. T. , M. S. , A. J. , N. Hk, and G. Pgd, Recombinant factor VIIa enhances deposition of platele ts with congenital or acquired ?IIb?3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor?independent thrombin generation, Blood, vol.101, issue.5, pp.1864-1870, 2003.

G. Jn and A. Rh, Drug-induced thrombocytopenia: pathogenesis, evaluation, and management, Hematology, vol.1, pp.153-158, 2009.

S. R. , E. Ml, S. E. Buccisano-f, V. A. , and A. S. , Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management, Thromb. Haemost, vol.99, issue.1, pp.4-13, 2008.

B. Km, C. Lj, R. Em, and B. Tp, Platelet size has diagnostic predictive value in patients with thrombocytopenia, Clin. Lab. Haematol, vol.27, issue.6, pp.370-373, 2005.

T. Dh, M. Mh, E. Ea, and G. A. , Flow-cytometric light scattering measurement of red blood cell volume and hemoglobin concentration, Appl. Opt, vol.24, issue.9, p.1355, 1985.

G. A. , L. P. , A. F. , G. G. , V. S. et al., Evaluation of platelet analysis on the ADVIA 120 hematology system, Laboratory Hematology, vol.7, pp.180-185, 2001.

Y. M. , A. I. , D. O. , A. M. , Z. C. et al., The acute effects of passive smoking on mean platelet volume in healthy volunteers, Angiology, vol.63, issue.5, pp.353-357, 2012.

W. Jg and E. G. , EDTA-induced changes in platelet structure and function: adhesion and spreading, Platelets, vol.11, issue.1, pp.56-61, 2000.

W. Jg, K. Md, and E. G. , EDTA induced changes in platelet structure and function: influence on particle uptake, Platelets, vol.10, issue.5, pp.327-337, 1999.

D. , B. L. Pino-m, N. F. , J. Jm, and H. M. , Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters, Thromb. Res, vol.126, issue.1, pp.30-35, 2010.

M. M. , A. U. , M. D. , W. L. , C. Es et al., Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system, Clin. Chem, vol.48, issue.6, pp.891-899, 2002.

M. Mg, C. E. , W. L. , C. Es, Z. D. et al., Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system, Cytometry, vol.38, issue.5, pp.250-255, 1999.

E. Van-cott, F. Sr, and K. , Effects of the Blood-Collection Tube Material and Long-term Storage on Platelet Activation Parameters on the ADVIA 120/2120 Hematology System, Laboratory Hematology, vol.11, issue.1, pp.71-75, 2005.
DOI : 10.1532/LH96.04070

H. Jj, Reference range of mean platelet volume, Thromb. Res, vol.129, issue.4, pp.534-535, 2012.

C. Sg, . Becker-rc, . Berger-pb, E. Bhatt-dl, and K. B. Jw, Mean platelet volume as a predictor of cardiovascular risk : a systematic review and meta-analysis, J. Thromb. Haemost, vol.8, issue.1, pp.148-156, 2010.

G. E. , B. Vl, L. Dk, P. Da, S. Mc et al., Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit, Transfusion, issue.10, pp.492034-2039, 2009.

M. A. De-pascalis-s, C. A. , L. C. , C. N. , and A. S. , Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes, Thromb. Haemost, issue.6, pp.991079-1084, 2008.

B. Cj, B. Gd, and L. Gyh, Assessment of platelet activation indices using the ADVIATM 120 amongst « high-risk » patients with hypertension, Ann. Med, vol.39, issue.1, pp.72-78, 2007.

K. S. Blann-ad and L. Gy, Platelet activation: assessment and quantification, Eur. Heart J, vol.22, issue.17, pp.1561-1571, 2001.

B. Sk, M. Eb, N. I. , W. T. , S. J. et al., Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, J. Thromb. Haemost, vol.8, issue.1, pp.157-162, 2010.

K. Hk, K. J. , H. Ck, L. Ds, P. S. et al., Prognostic value of platelet indices as determined by ADVIA 120 in patients suspected of having disseminated intravascular coagulation, International Journal of Laboratory Hematology, vol.30, issue.2, pp.117-123, 2008.

H. Y. Brown-as, . De-belder-a, B. J. Beacon-h, and S. R. , Megakaryocyte Ploidy and Platelet Changes in Human Diabetes and Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.4, pp.802-807, 1997.
DOI : 10.1161/01.ATV.17.4.802

D. S. , M. Cd, C. , and F. C. , Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications, Am. J. Gastroenterol, vol.99, issue.5, pp.938-945, 2004.

K. B. , T. A. , K. U. , K. O. , A. A. et al., Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis, Joint Bone Spine, issue.3, pp.75291-294, 2008.

A. Ma, A. Ap, and K. Hr, Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease, Ann. Hematol, vol.83, issue.6, pp.331-335, 2004.

O. Jc, J. J. , and S. Jm, Platelet distribution width for differential diagnosis of thrombocytosis, Clin. Chem, vol.43, issue.6, pp.1072-1076, 1997.

S. Yh, P. Sh, K. Je, A. Jy, S. Yh et al., Evaluation of platelet indices for differential diagnosis of thrombocytosis by ADVIA 120, Korean J Lab Med, vol.29, issue.6, pp.505-509, 2009.

B. Mj, J. Z. , B. S. , C. R. , and T. S. , Comparison of platelet activation in platelet concentrates measured by flow cytometry or ADVIA 212, Vox Sang, vol.101, issue.2, pp.122-130, 2011.

G. A. , L. P. , A. F. , V. S. , S. Mm et al., Assessment of in vitro platelet activation by Advia 120 platelet parameters, Lab. Hematol, vol.9, issue.3, pp.132-137, 2003.

P. Ij, L. Ya, and C. Sr, Usefulness of delta value of platelet parameters on ADVIA 120 for the functional reactivity of stored platelets, J. Clin. Lab. Anal, vol.24, issue.1, pp.38-43, 2010.

A. , A. , R. Jc, V. N. , J. Jm et al., Automated assessment of the neutrophil and platelet activation status in patients with essential thrombocythemia, Platelets, vol.23, issue.5, pp.336-343, 2011.

B. Sh, L. J. , R. Kh, and K. J. , Platelet activation in patients with diabetic retinopathy, Korean J. Ophthalmol, vol.17, issue.2, pp.140-144, 2003.

A. Ce, B. Ff, C. Es, P. V. , G. A. et al., Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty, Thromb. Haemost, issue.6, pp.921207-1213, 2004.

L. Ya and H. Bh, Evaluation of platelet parameters on the ADVIA 120 as the quality indicator for stored platelets, Clin. Lab. Haematol, vol.24, issue.6, pp.377-384, 2002.

L. and L. Sous-presse, Thrombopénies constitutionnelles : de la bonne utilisation des paramètres plaquettaires de l'hémogramme et de la morphologie pour orienter le diagnostic

P. Pd, S. Jm, M. Wb, and M. D. , A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size, Pediatr Blood Cancer, vol.56, pp.1127-1129, 2011.

S. Sj, M. J. Denton-k, and P. Wn, Automated counting of platelets on the Bayer ADVIA 120 analyser, Clin. Lab. Haematol, vol.21, issue.2, pp.113-117, 1999.